VSIG4 and diffuse large B-cell lymphoma: In this study, we employed bioinformatics methods to identify prognostic markers that are associated with M2-like TAM, leading to the discovery of a macrophage-derived surface marker, VSIG4 (V-set and immunoglobulin domain containing 4), which has the potential to predict unfavorable prognosis of DLBCL.